Pipeline Watch: Japanese Approvals Dominated As 2022 Drew To A Close
The Week In R&D
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
